News
July 25, 2007 - St. Jude Medical, Inc. announced the first patient implant in its clinical trial of Trifecta, a new ...
July 24, 2007
News
July 25, 2007 - Teleflex Incorporated, a diversified company expanding medical technology business, and Arrow ...
July 24, 2007News
July 25, 2007 - Researchers have confirmed that six new genetic variants increase the likelihood of developing coronary ...
July 24, 2007Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
July 24, 2007 – Biotonik announced that it has enrolled the first patient and largest trial, REPLACE Registry, which ...
July 23, 2007News
July 24, 2007 - A new U.S. study published in the early online edition of Circulation, the journal of the American Heart ...
July 23, 2007News
July 22, 2007 – ev3 Inc. and FoxHollow Technologies, Inc. announced a definitive agreement by which ev3 and FoxHollow ...
July 22, 2007Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
July 23, 2007 - Teleflex Inc., a global supplier of disposable medical products used in critical care, specialty medical, and surgical applications and Arrow International Inc. announced today that they have entered into a definitive agreement pursuant to which Teleflex will acquire Arrow in an all cash transaction valued at approximately $2 billion.
July 22, 2007News
Source: Wall Street Journal Online July 20, 2007 - U.S. doctors implanted fewer coronary stents in June than any other ...
July 19, 2007News
July 19, 2007 – Abbott announced that the first patient was enrolled in its XIENCE V SPIRIT WOMEN clinical trial, the ...
July 19, 2007Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
July 20, 2007 – Despite forecasts by analysts at Thomson Financial that Boston Scientific Corp. would earn $150 million ...
July 19, 2007News
July 20, 2007 – Oraganogenesis Inc. announced that it has received regulatory approval in Canada and Europe for BioSTAR, a device that incorporates a bioresorbable collagen scaffold used to treat patent foramen ovale (PFO), a hole in the heart that is usually asymptomatic.
July 19, 2007News
July 19, 2007 – AtCor Medical Holdings Ltd., the developer and marketer of the SphygmoCor system, which noninvasively ...
July 18, 2007Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
July 18, 2007 - An analysis based on computerized simulation models suggests that the lifetime risk of cancer associated ...
July 17, 2007News
July 18, 2008 - Cardium Therapeutics announced that the FDA has given it clearance for fast track designation to its ...
July 17, 2007News
July 18, 2007 - In a related study of over 25,000 initially healthy women, higher triglyceride levels measured after not fasting is associated with an increased risk for cardiovascular events, but his association was not found for triglyceride levels measured after fasting, according to a study in the July 18 issue of JAMA.
July 17, 2007© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now